CENSORIAL: Music Therapy as a Tool for Anxiety Reduction in Localized Breast Cancer
Study Details
Study Description
Brief Summary
Breast cancer is the number one cancer in women worldwide, with 58,500 new cases in metropolitan France in 2018. The announcement of the cancer, the treatment methods and their side effects can generate unpleasant emotions, such as fear, for example, and the resources for coping with them differ according to the patient. Coming to the hospital as an outpatient for chemotherapy is in itself a source of anxiety.
The use of music in the treatment process is a therapy that can help patients to reduce the intensity of their unpleasant emotions. Active music therapy involves the patient playing an instrument, including voice and body movement in rhythm, without requiring any musical skills. The presence of a qualified music therapy professional is essential, particularly in the reception of the emotions that may be generated during the sessions. These sessions can be collective or individual. In breast cancer, music therapy has been shown to be effective in reducing pain, anxiety, depressive symptoms and length of hospitalisation in patients undergoing mastectomy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Music therapy arm A music therapy will be offered to patients before the first 3 chemotherapy cycles |
Behavioral: Music therapy
Music therapy is a technique of care, accompaniment and support, which aims to improve health and well-being.
|
No Intervention: Standard care arm Standard patient care, no intervention |
Outcome Measures
Primary Outcome Measures
- To evaluate the impact of music therapy on anxiety in breast cancer patients undergoing adjuvant or neoadjuvant chemotherapy. [5 months]
The evolution of anxiety before the first and before the 3rd chemotherapy session, measured by the questionnaire STAI etat score.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patient with localized breast cancer
-
Indication for adjuvant or neoadjuvant chemotherapy
-
Patient > 18 years of age
-
Patient with signed consent
-
Patient affiliated to a social security scheme
Exclusion Criteria:
-
Metastatic patient
-
Triple negative patient
-
Patient not eligible for curative surgery
-
Patient who has already received chemotherapy
-
Unaided deaf patient
-
Women who are pregnant, likely to be pregnant or breastfeeding
-
A patient presenting a depressive episode or a psychotic pathology at the time of the initial consultation
-
Patient who does not understand French
-
Cognitive disorder or inability to understand,
-
Patient protected by law, under court protection, guardianship or curatorship
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Institut Cancerologie de l'Ouest
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- ICO-2022-21